PLUR · Pluri Inc.
$1.58
-0.10 (-5.95%)
At close · Jul 29
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“According to our management's estimates, we have sufficient resources to meet our operating obligations for a period of less than three months from the issuance date of our interim unaudited condensed consolidated financial statements, which was May 14, 2026. These conditions raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$17.05M
Shares
10.79M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.58
Open$1.67
Day$1.57–1.67
52W$1.56–5.68
Avg vol 30d36K
Short int24K · 0.2% float · 1.0d
Short vol3%
DataJan 2020–Jul 2026
Filing10-Q · May 14
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−50%
below
Price vs 50-day avg
−25%
below
RSI (14)
33
neutral
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−24%
trailing
6-month return
−52%
trailing
YTD return
−47%
this year
Relative strength
−58%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
6 of 14 funds reported for Jun 30 · net +88 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.22% of float · ▲ +56.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
14 holders — mid 2-yr range
Squeeze score
36
low risk · 0–100
Fundamentals
Revenue growth
+310%
Y/Y
Gross margin
49%
contracting
EPS growth
+11%
Y/Y
Free cash flow
$-19.8M
Balance sheet
$4.6M
net cash
Quant / Vol
risk profile
Volatility
72%
annualized · 1-yr
Max drawdown
−72%
past year
ATR
10.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−50%
Bearish
Price vs 50-day avg
−25%
Bearish
RSI (14)
33
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
6 of 14 funds reported for Jun 30 · net +88 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.22% of float · ▲ +56.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
14 holders — mid 2-yr range
Price context
position in its 52-week range
52-wk low $2
Now $2 · 0%
52-wk high $6
vs 200-day avg -50%
vs 50-day avg -25%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PLUR
this stock
Pluri Inc.
|
$17.05M | -47.2% | +309.8% | — | 0.2% |
|
ONC
BeOne Medicines Ltd.
|
$472.90B | +7.7% | +22179.2% | 962.4 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$122.67B | +6.6% | +46.2% | 28.7 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.91B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$55.21B | +4.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PLUR | -14.6% | -24.4% | -52.1% | -24.4% | -47.2% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | -12.2% | -22.1% | -58.4% | -22.1% | -54.1% |